These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9446656)

  • 1. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.
    Brugnoni D; Notarangelo LD; Sottini A; Airò P; Pennacchio M; Mazzolari E; Signorini S; Candotti F; Villa A; Mella P; Vezzoni P; Cattaneo R; Ugazio AG; Imberti L
    Blood; 1998 Feb; 91(3):949-55. PubMed ID: 9446656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected and variable phenotypes in a family with JAK3 deficiency.
    Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
    Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
    Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
    Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
    Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
    J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
    Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
    Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
    Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
    Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
    Candotti F; Oakes SA; Johnston JA; Giliani S; Schumacher RF; Mella P; Fiorini M; Ugazio AG; Badolato R; Notarangelo LD; Bozzi F; Macchi P; Strina D; Vezzoni P; Blaese RM; O'Shea JJ; Villa A
    Blood; 1997 Nov; 90(10):3996-4003. PubMed ID: 9354668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.
    Thomis DC; Lee W; Berg LJ
    J Immunol; 1997 Nov; 159(10):4708-19. PubMed ID: 9366394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.
    Cattaneo F; Recher M; Masneri S; Baxi SN; Fiorini C; Antonelli F; Wysocki CA; Calderon JG; Eibel H; Smith AR; Bonilla FA; Tsitsikov E; Giliani S; Notarangelo LD; Pai SY
    J Allergy Clin Immunol; 2013 Apr; 131(4):1136-45. PubMed ID: 23384681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice.
    Suzuki K; Nakajima H; Saito Y; Saito T; Leonard WJ; Iwamoto I
    Int Immunol; 2000 Feb; 12(2):123-32. PubMed ID: 10653847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell development and activation in Jak3-deficient mice.
    Baird AM; Thomis DC; Berg LJ
    J Leukoc Biol; 1998 Jun; 63(6):669-77. PubMed ID: 9620658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency.
    Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
    Br J Haematol; 2001 Mar; 112(3):671-6. PubMed ID: 11260071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
    Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
    Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.
    Buckley RH; Schiff RI; Schiff SE; Markert ML; Williams LW; Harville TO; Roberts JL; Puck JM
    J Pediatr; 1997 Mar; 130(3):378-87. PubMed ID: 9063412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.
    Wen R; Wang D; McKay C; Bunting KD; Marine JC; Vanin EF; Zambetti GP; Korsmeyer SJ; Ihle JN; Cleveland JL
    Mol Cell Biol; 2001 Jan; 21(2):678-89. PubMed ID: 11134353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment.
    Bozzi F; Lefranc G; Villa A; Badolato R; Schumacher RF; Khalil G; Loiselet J; Bresciani S; O'Shea JJ; Vezzoni P; Notarangelo LD; Candotti F
    Br J Haematol; 1998 Sep; 102(5):1363-6. PubMed ID: 9753072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.
    Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Pérez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF
    Immunol Rev; 2000 Dec; 178():39-48. PubMed ID: 11213805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.
    Khanolkar A; Wilks JD; Liu G; Simpson BM; Caparelli EA; Kirschmann DA; Bergerson J; Fuleihan RL
    Immunol Res; 2020 Feb; 68(1):13-27. PubMed ID: 32215810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jak3 and the pathogenesis of severe combined immunodeficiency.
    O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
    Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.